Consulate General of Canada in Shanghai China

For more than 120 years, the Trade Commissioner Service (TCS) has been helping Canadian companies navigate international markets. Our trade commissioners in more than 160 cities worldwide can provide you with key business insights and access to an unbeatable network of international contacts. The TCS provides Canadian businesses and organizations with tailored advice to help them enter new markets outside of Canada.
Lulu Mi
Life Sciences Trade Commissioner 
Functionality
Dr Kshitij Soni
LinkedIn logo CEO 
Functionality

Nodes Advisors AG Switzerland

We are a corporate finance firm committed to advancing the field of Healthcare through advisory,and investments.

We advise and buy-side and sell side corporates and Family offices on investment in Healthcare & life Sciences across Switzerland, Europe and the US.
Company Size (Fulltime employees)
Year of foundation
2018
Headquartner in China
Plan in China
We would like to partner with strong Chinese funds who are interested in incubating and investing in European and US early stage companies and facilitate market acess and technology integration in chinese market.
Eliott Harfouche
Partner 
Functionality

Rius Medical UG (Haftungsbeschränkt) Germany

About Rius Medical: Rius Medical is designing and developing a new generation of Commercial cell therapies positioned at the crossroads of two high-potential programs: (1.) genetically engineering red blood cells for an entirely new class of cellular medicines and (2.) potent NK-cell therapy products. Due to their mechanism of action, engineered red blood cells demonstrated treatments for wide range of patients from starving cancer cells to targeting autoimmune diseases. Building on exceptional progress in cell therapies, Rius Medical is in a unique position to offer Third-Generation red blood cells for drug delivery that addresses Rare Diseases, Oncology and Autoimmune Diseases like type 1 diabetes! Furthermore, harnessing the unique power of natural killer (NK) cells enables the treatment of cancer and infectious diseases such as Influenza virus or SARS-Coronavirus (i.e. COVID-19 pandemic). That’s right, NK-cells as vaccine delivery NOT for antibodies but for “memory T cells” activation!
Company Size (Fulltime employees)
Year of foundation
2016
Looking for
Please specify your partnering goal
Bring together technology & funds for improving “China Focus” healthcare situation on an equal basis.
Funding Status
Seeking investors for Series A
Now raising (In USD)
1,665,454 USD
Headquartner in China
Plan in China
Rius Medical unique position as CDMO (contract development and manufacturing organization) is not limited to drug delivery. Yes, drug delivery programs bring EUR 130 million revenue sooner than “Rius Medical’s blood transfusion” program. However, Rius Medical’s path to becoming a market leader in healthcare in promoting excellence, innovation and good business practices, is driven by its “blood transfusion” program. The Plan in China is local Jobs in China for manufacturing of stem cells derived “blood transfusion” products. Also drug delivery via "Third-Generation red blood cells for drug delivery" that addresses Rare Diseases, Oncology and Autoimmune Diseases like type 1 diabetes, is region-specific; as in Europe, USA and China regions due to ABO blood group and other antigens being region-specific!
Assets Information 1: Name|Description|Indications|Stage|IP countries
eRBC|Red Blood Cells for Drug Delivery|Oncology|Prototype Assembly|N/A
Biotech/Pharma Asset Stage
Mr Denis Demarais
Mr Denis Demarais
LinkedIn logo Founder and CEO 
Functionality

Wanbang Biopharmaceuticals (Group) Co., Ltd China

Wanbang Biopharmaceuticals (Wanbang Biopharma) is a core member of Shanghai Fosun PHARMACEUNCAL (group) Co., Ltd.(Fosun Pharma”, Stock code: 600196-SH,02196-HK).
Dr Di Simon
高级BD经理